Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

76.53 -0.31 (-0.40%)
Official Closing Price Updated: 4:10 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Where Edwards Lifesciences Stands With Analysts
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter: 
Via Benzinga
Edwards Lifesciences Q4 Earnings Fall Short Of Expectations, Reaffirms FY22 Outlook
Heart device company Edwards Lifesciences Corp (NYSE: EW) posted Q4 adjusted EPS of $0.51, compared to $0.50 posted a year ago and below the consensus of $0.55.... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Reneo Pharmaceuticals (NASDAQ:RPHM 
Via Benzinga
Edwards Lifesciences: Q4 Earnings Insights
Edwards Lifesciences (NYSE:EW) reported its Q4 earnings results on Wednesday, January 26, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Edwards Lifesciences Dips On Narrow Quarterly Miss, Light Outlook
Edwards issued light 2022 guidance after a fourth-quarter disappointment. 
Via Investor's Business Daily
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Watch for Continued Gains in Shares of Edwards Lifesciences Corporation (EW)
Via Investor Brand Network
Expert Ratings For Edwards Lifesciences
Edwards Lifesciences (NYSE:EW) has observed the following analyst ratings withi... 
Via Benzinga
Earnings Scheduled For January 26, 2022
Companies Reporting Before The Bell • Blue Foundry (NASDAQ:BLFY) is projected to report earnings for its fourth quarter. • First BanCorp (NYSE:FBP) is likely to... 
Via Benzinga
5 Big Cap Earnings All Stars to Watch This Week
Some of these companies have perfect 5-year earnings surprise track records, even beating through the early months of the pandemic. It’s impressive. 
Via Talk Markets
Preview: Edwards Lifesciences's Earnings
Edwards Lifesciences (NYSE:EW) is set to give its latest quarterly earnings report on Wednesday, 2022-01-26. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the... 
Via Benzinga
$100 Invested In This Stock 10 Years Ago, Would Be Worth This Much
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 10 years by 12.27% on an annualized basis. Buying $100 In EW: 10 years ago, an investor could have... 
Via Benzinga
Where Edwards Lifesciences Stands With Analysts
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW)... 
Via Benzinga
CNBC's Final Trades: Match Group, PayPal, Edwards Lifesciences And This Hospitality Major
On CNBC’s “Halftime Report Final ... 
Via Benzinga
Edwards Lifesciences Corp. (EW) Looks to Continue to Trade Above its Annual-High Share Price Today
Via Investor Brand Network
Jim Cramer Shares His Thoughts On Medtronic, Peloton Interactive And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Duluth Holdings Inc. (NASDAQ: 
Via Benzinga
Watch for Continued Gains in Shares of Edwards Lifesciences Corporation
Edwards Lifesciences Corporation (NYSE: EW) traded at a new 12-month high today of $123.56. So far today approximately 1.6 million shares have been exchanged, as compared to an... 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Barclays boosted the price target on Sysco Corporation (NYSE: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021
Upgrades According to Morgan Stanley, the prior rating for Definitive Healthcare Corp (NASDAQ: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE: 
Via Benzinga
10 Biggest Price Target Changes For Friday
Keybanc boosted the price target on Broadcom Inc. (NASDAQ: 
Via Benzinga
Where Edwards Lifesciences Stands With Analysts
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW)... 
Via Benzinga
10 Biggest Price Target Changes For Thursday
SVB Leerink boosted the price target on Edwards Lifesciences Corporation (NYSE: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
Upgrades According to TD Securities, the prior rating for MAG Silver Corp (AMEX: 
Via Benzinga
Notable Edwards Lifesciences Insider Trades $4.9M In Company Stock
Michael Mussallem, Chairman And CEO at Edwards Lifesciences (NYSE:EW), made a large buy and sell of company shares on November 9, according to a new SEC filing. What Happened: A... 
Via Benzinga
Topics Regulatory Compliance
Edwards' Transcatheter Tricuspid Replacement System Shows Favorable Patient Outcomes
​​​​Edwards Lifesciences Corporation (NYSE: EW) announced results from the TRISCEND study of its EVOQUE transcatheter tricuspid valve replacement system. Patients... 
Via Benzinga
Edwards Lifesciences Says Delta Variant Drove Procedure Deferrals In Q3
Edwards Lifesciences Corp (NYSE: EW) reported Q3 earnings of $340.1 million, or $0.54 per share, ahead of the consensus of $0.53. Sales grew 15% to $1.31 billion;... 
Via Benzinga
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In... 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.